News + Events


OCT 5-6, 2023
Dr. Csete presenting at Bioventure Nexus, the premier event for innovation and networking in the Synthetic Biology, Biotech, Life Science, Food Tech, and AI in Bio industries-- at the stunning JW Marriott/Ritz Carlton in Downtown Los Angeles

SEPT 5-7, 2023
Join us in Europe: OkuloVision will be presenting at the Phacilitate meeting in Lisbon, Portugal. On the panel with Dr. Csete, Rui Sousa, CEO of Stemmatters will be discussing Stemmatters role in development and GMP manufacturing of OkuloVision's cone progenitor cells. 

MAY 1, 2023
OkuloVision’s CEO, Marie Csete, is co-author on a paper published in Advanced Science, describing identification of the cancer stem cell for Wilm’s tumor—The ambitious study, led by Laura Perin PhD, is an important advance in understanding the most common kidney cancer in children, and was featured in a Press Release from Children’s Hospital Los Angeles

JUNE 2023
We are pleased to announce that OkuloVision won the “People’s Choice” Award at OctaneOC‘s Ophthalmology Tech Forum in Newport Beach, CA

JANUARY 2023
OkuloVision welcomes Paul Sieving MD, PhD to its Science Advisory Board

NOV 12, 2022
OkuloVision CEO Marie Csete interviewed in Panel Discussion on Emerging Therapies and Research for Inherited Retinal Diseases with Ben Shaberman of Foundation Fighting Blindness

OCT 6-7, 2022
OkuloVision chosen as a featured emerging company at the 24th Annual SoCalBio Conference at the Long Beach Westin

OCT 2022
OkuloVision welcomes Nuno Madeira do O PhD as COO

SEPT 2022
OkuloVision welcomes John Sinden PhD and Joseph Wu MD, PhD to its Science Advisory Board

AUG 2022
OkuloVision signs option to license cone progenitor cell technology from Mass Eye & Ear

JUNE 2022
OkuloVision begins technology transfer of cone progenitor (GMP) manufacturing procedures with Stemmatters, Guimaraes Portugal.

MAR 2022
OkuloVision registered to do business in the State of California

FEB 28 2022
OkuloVision incorporated in Delaware